BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sprout Pharmaceuticals Tries Again With "Pink Viagra"


6/27/2013 7:40:11 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Some three years after regulators in the USA rejected flibanserin, Sprout Pharmaceuticals has resubmitted the female sexual dysfunction drug acquired from Boehringer Ingelheim to the Food and Drug Administration. In June 2010, the agency's Reproductive Health Drugs Advisory Committee voted 10-1 that flibanserin is not effective in increasing female libido and unanimously ruled that its potential side effects, such as loss of consciousness and depression, were not acceptable. Boehringer discontinued development of the compound a few months later but then sold it to Sprout in 2011.

Help employers find you! Check out all the jobs and post your resume.



 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES